Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures

Experimental Neurology

Volumn 219, Issue 2, 2009, Pages 586-590

  Aksenov, Michael Y ^a   Aksenova, Marina V ^a   Mactutus, Charles F ^a   Booze, Rosemarie M ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; Cell culture; Cysteine rich domain; Hiv 1 Tat; Neurotoxicity

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 9; CYSTEINE; GLYCINE; TRANSACTIVATOR PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENE MUTATION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MITOCHONDRION; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CASPASES; CELLS, CULTURED; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE PRODUCTS, TAT; HIPPOCAMPUS; HUMANS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTIONAL ACTIVATION;

EID: 69749116487     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.07.005     Document Type: Article

References (33)

1. Aksenov M.Y., Aksenova M.V., Nath A., Ray P.D., Mactutus C.F., and Booze R.M. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27 (2006) 217-228
2. Aksenova M.V., Aksenov M.Y., Mactutus C.F., and Booze R.M. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp. Neurology 215 (2009) 253-263
3. Chandra T., Maier W., König H.G., Hirzel K., Kögel D., Schüler T., Chandra A., Demirhan I., and Laube B. Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits. Neuroscience 134 (2005) 145-153
4. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., and Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11 (1997) 1421-1431
5. Cossarizza A. Apoptosis and HIV infection: about molecules and genes. Curr. Pharm. Des. 14 (2008) 237-244
6. Egelé C., Barbier P., Didier P., Piémont E., Allegro D., Chaloin O., Muller S., Peyrot V., and Mély Y. Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat. Retrovirology 5 (2008) 62
7. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., and Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67 (1993) 277-287
8. Frankel A.D., Bredt D.S., and Pabo C.O. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240 (1988) 70-73
9. Garber M.E., Wei P., KewalRamani V.N., Mayall T.P., Hermann C.H., Rice A.P., Littman D.R., and Jones K.A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12 (1998) 3512-3527
10. Hetzer C., Dormeyer W., Schnölzer M., and Ott M. Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes Infect. 7 (2005) 1364-1369
11. Huang H.W., and Wang K.T. Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein. Biochem. Biophys. Res. Commun. 227 (1996) 615-621
12. Hult B., Chana G., Masliah E., and Everall I. Neurobiology of HIV. Int. Rev. Psychiatry 20 (2008) 3-13
13. Jones G., and Power C. Regulation of neural cell survival by HIV-1 infection. Neurobiol. Dis. 21 (2006) 1-17
14. King J.E., Eugenin E.A., Buckner C.M., and Berman J.W. HIV tat and neurotoxicity. Microbes Infect. 8 (2006) 1347-1357
15. Koutsiliery E., Sopper S., Scheller C., ter Meulen V., and Riederer P. Involvement of dopamine in the progression of AIDS dementia complex. J. Neural Transm. 109 (2002) 399-410
16. Kruman I.I., Nath A., and Mattson M.P. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload and oxidative stress. Exp. Neurol. 154 (1998) 276-288
17. Li W., Huang Y., Reid R., Steiner J., Malpica-Llanos T., Darden T.A., Shankar S.K., Mahadevan A., Satishchandra P., and Nath A. NMDA receptor activation by HIV-Tat protein is clade dependent. J. Neurosci. 28 (2008) 12190-12198
18. Manji H., and Miller R. Neurology of HIV infection. J. Neurol. Neurosurg. Psychiatry 75 (2004) 29-35
19. Mishra M., Vetrivel S., Siddappa N.B., Ranga U., and Seth P. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C of human neurons: significance of dicysteine C30C31 motif. Ann. Neurol. 63 (2008) 366-376
20. Misumi S., Takamune N., Ohtsubo Y., Waniguchi K., and Shoji S. Zn2 Binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis. AIDS Res. Hum. Retrovir. 20 (2004) 297-304
21. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D.S., Haughey N., and Geiger J.D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70 (1996) 1475-1480
22. Nath A., Conant K., Chen P., Scott C., and Major E.O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem. 274 (1999) 17098-17102
23. Navia B.A., Cho E.S., Petito C.K., and Price R.W. The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19 (1986) 525-535
24. Ozdener H. Molecular mechanisms of HIV-1 associated neurodegeneration. J. Biosci. 30 (2005) 391-405
25. Ranga U., Shankarappa R., Siddappa N.B., Ramakrishna L., Nagendran R., Mahalingam M., Mahadevan A., Jayasuryan N., Satishchandra P., Shankar S.K., and Prasad V.R. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J. Virol. 78 (2004) 2586-2590
26. Roshal M., Zhu Y., and Planelles V. Apoptosis in AIDS. Apoptosis 6 (2001) 103-116
27. Sadaie M.R., Mukhopadhyaya R., Benaissa Z.N., Pavlakis G.N., and Wong-Staal F. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication. AIDS Res. Hum. Retrovir. 6 (1990) 1257-1263
28. Shojania S., and O'Neil J.D. HIV-1Tat is natively unfolded protein.The solution conformation and dynamics of reduced Tat-(1-72) by NMR spectroscopy. J. Biol. Chem. 281 (2006) 8347-8356
29. Song L., Nath A., Geiger J.D., Moore A., and Hochman S. Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-d-aspartate receptors at an allosteric zinc-sensitive site. J. Neurovirol. 9 (2003) 399-403
30. Tardieu M., Hery C., Peudenier S., Boespflug O., and Montagnier L. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann. Neurol. 32 (1992) 11-17
31. Van de Bovenkamp M., Nottet H.S., and Pereira C.F. Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia. Eur. J. Clin. Invest. 32 (2002) 619-627
32. Zeron M.M., Fernandes H.B., Krebs C., Shehadeh J., Wellington C.L., Leavitt B.R., Baimbridge K.G., Hayden M.R., and Raymond L.A. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease. Mol. Cell. Neurosci. 25 (2004) 469-479
33. Zhu J., Mactutus C.F., Wallace D.R., and Booze R.M. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes. J. Pharmacol. Exp. Ther. 329 (2009) 1071-1083